Yukang Lin

2.9k total citations · 1 hit paper
58 papers, 2.3k citations indexed

About

Yukang Lin is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Yukang Lin has authored 58 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Radiology, Nuclear Medicine and Imaging, 22 papers in Oncology and 17 papers in Pathology and Forensic Medicine. Recurrent topics in Yukang Lin's work include Radiopharmaceutical Chemistry and Applications (28 papers), Monoclonal and Polyclonal Antibodies Research (24 papers) and Lymphoma Diagnosis and Treatment (17 papers). Yukang Lin is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (28 papers), Monoclonal and Polyclonal Antibodies Research (24 papers) and Lymphoma Diagnosis and Treatment (17 papers). Yukang Lin collaborates with scholars based in United States, South Africa and Canada. Yukang Lin's co-authors include Oliver W. Press, Brian G. Till, Michael C. Jensen, Jinjuan Wang, John M. Pagel, Philip D. Greenberg, Ajay K. Gopal, Andrew Raubitschek, Stephen J. Forman and Stanley R. Riddell and has published in prestigious journals such as Journal of the American Chemical Society, Blood and The Journal of Immunology.

In The Last Decade

Yukang Lin

57 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results

2012 431 citations Brian G. Till, Michael C. Jensen et al. Blood profile →

Peers

Yukang Lin

ONCOL

RNMI

IMMUN

GENET

Mariangela Figini Italy

Nathalie Scholler United States

Hong-Fen Guo United States

Patrizio Giacomini Italy

Sarwish Rafiq United States

Elmer Santos United States

Mathilde Poussin United States

Jean‐Baptiste Latouche France

Tove Olafsen United States

Joshua Brody United States

Mariangela Figini Italy

Yukang Lin

1.3k ×1.0

ONCOL

531 ×0.7

RNMI

999 ×1.6

683 ×1.4

IMMUN

389 ×1.0

GENET

Citations per year, relative to Yukang Lin Yukang Lin (= 1×) peers Mariangela Figini

Countries citing papers authored by Yukang Lin

Since Specialization

Citations

This map shows the geographic impact of Yukang Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukang Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukang Lin more than expected).

Fields of papers citing papers by Yukang Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukang Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukang Lin. The network helps show where Yukang Lin may publish in the future.

Co-authorship network of co-authors of Yukang Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yukang Lin. A scholar is included among the top collaborators of Yukang Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukang Lin. Yukang Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Yukang, et al.. (2025). A perspective on the application of macrocyclic design strategies in antitumor drugs. Bioorganic Chemistry. 156. 108190–108190. 2 indexed citations

Zhang, Bei, Yukang Lin, Ting Wang, et al.. (2025). Structure-Guided Discovery of Novel N⁴-(Substituted Thiazol-2-yl)-N²-(4-Substituted phenyl)pyrimidine-2,4-Diamines as Potent CDK2 and CDK9 Dual Inhibitors with High Oral Bioavailability. Journal of Medicinal Chemistry. 68(2). 1693–1715. 4 indexed citations

Qin, Yuting, Lei Li, Wenhui Zhang, et al.. (2024). Targeting hyperactive mitochondria in activated HSCs and inhibition of liver fibrogenesis in mice using sorafenib complex micelles. International Journal of Pharmaceutics. 669. 125058–125058. 1 indexed citations

Zhang, Zhenyang, Weijing Cai, Zhi-Nuan Hong, et al.. (2022). A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer. Translational Lung Cancer Research. 11(1). 75–86. 7 indexed citations

Orozco, Johnnie J., Aimee L. Kenoyer, Yukang Lin, et al.. (2020). Therapy of Myeloid Leukemia using Novel Bispecific Fusion Proteins Targeting CD45 and 90Y-DOTA. Molecular Cancer Therapeutics. 19(12). 2575–2584. 8 indexed citations

O’Steen, Shyril, Damian J. Green, Ajay K. Gopal, et al.. (2017). Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas. Cancer Research. 77(14). 3885–3893. 23 indexed citations

Yang, Qi, Christina L. Parker, Yukang Lin, et al.. (2017). Pretargeting with bispecific fusion proteins facilitates delivery of nanoparticles to tumor cells with distinct surface antigens. Journal of Controlled Release. 255. 73–80. 17 indexed citations

Green, Damian J., Shani L. Frayo, Yukang Lin, et al.. (2016). Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell Cancers. Cancer Research. 76(22). 6669–6679. 22 indexed citations

Frost, Sofia H.L., Shani L. Frayo, Brian W. Miller, et al.. (2015). Comparative Efficacy of 177Lu and 90Y for Anti-CD20 Pretargeted Radioimmunotherapy in Murine Lymphoma Xenograft Models. PLoS ONE. 10(3). e0120561–e0120561. 27 indexed citations

10.

Green, Damian J., Nural Orgun, Jon C. Jones, et al.. (2013). A Preclinical Model of CD38-Pretargeted Radioimmunotherapy for Plasma Cell Malignancies. Cancer Research. 74(4). 1179–1189. 40 indexed citations

11.

Budde, Lihua E., Carolina Berger, Yukang Lin, et al.. (2013). Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma. PLoS ONE. 8(12). e82742–e82742. 160 indexed citations

12.

Till, Brian G., Michael C. Jensen, Jinjuan Wang, et al.. (2012). CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results. Blood. 119(17). 3940–3950. 431 indexed citations breakdown →

13.

Park, Steven, Donald K. Hamlin, Yukang Lin, et al.. (2011). Pretargeted Radioimmunotherapy Using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma. Clinical Cancer Research. 17(23). 7373–7382. 27 indexed citations

14.

Nemecek, Eneida R., Damian J. Green, Darrell R. Fisher, et al.. (2008). Extracorporeal Adsorption Therapy: A Method to Improve Targeted Radiation Delivered by Radiometal-Labeled Monoclonal Antibodies. Cancer Biotherapy and Radiopharmaceuticals. 23(2). 181–191. 5 indexed citations

15.

James, Scott E., Philip D. Greenberg, Michael C. Jensen, et al.. (2008). Antigen Sensitivity of CD22-Specific Chimeric TCR Is Modulated by Target Epitope Distance from the Cell Membrane. The Journal of Immunology. 180(10). 7028–7038. 196 indexed citations

16.

Lin, Yukang, et al.. (2006). A Genetically Engineered Anti-CD45 Single-Chain Antibody-Streptavidin Fusion Protein for Pretargeted Radioimmunotherapy of Hematologic Malignancies. Cancer Research. 66(7). 3884–3892. 51 indexed citations

17.

Onitilo, Adedayo A., et al.. (2004). Race, education, and knowledge of bone marrow registry: Indicators of willingness to donate bone marrow among African Americans and Caucasians. Transplantation Proceedings. 36(10). 3212–3219. 19 indexed citations

18.

Bucheit, Amanda D., Shaji Kumar, Deanna M. Grote, et al.. (2003). An oncolytic measles virus engineered to enter cells through the CD20 antigen. Molecular Therapy. 7(1). 62–72. 72 indexed citations

19.

Sanderson, James, et al.. (2001). Preclinical Evaluation of a Humanized NR-LU-10 Antibody-Streptavidin Fusion Protein for Pretargeted Cancer Therapy. Cancer Biotherapy and Radiopharmaceuticals. 16(2). 109–123. 28 indexed citations

20.

Lin, Yukang & Gerald R. Smith. (1995). Molecular cloning of the meiosis-induced rec10 gene of Schizosaccharomyces pombe. Current Genetics. 27(5). 440–446. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact